Posts Tagged ‘digital therapeutic’
Update: A life of cognitive and physical exercise helps you stay sharp in your 70s and beyond
Welcome to a new edition of SharpBrains’ e‑newsletter, featuring 13 fascinating brain research findings, useful resources–and a brain teaser to test your attention skills. #1. Good news of the month: Elders today are in significantly better shape–physically and cognitively–than three decades ago #2. A distinction WITH a difference: Actual, sustained practice–not mere knowledge–is needed to…
Read MoreClick Therapeutics and Boehringer Ingelheim partner to develop and market a digital therapeutic to treat schizophrenia
Boehringer Ingelheim, Click Therapeutics ink $500M+ digital therapeutics development, commercialization deal (MobiHealthNews): International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia.
Read MoreThe FDA clears Somryst, Pear’s digital therapeutic to treat chronic insomnia
Pear gets FDA clearance for insomnia therapeutic (MedCity News): “Pear Therapeutics received marketing authorization for its third product — a digital therapeutic intended to treat chronic insomnia. Called Somryst, the app is available by prescription only. It consists of a nine-week program that includes cognitive behavioral therapy and restricting sleep to a limited window of time
Read MoreLatest brain research, tools and teasers to think outside the mental health status quo box
__ Time for a new edition of SharpBrains’ e‑newsletter, featuring a range of research findings, resources, brain teasers and riddles to help translate emerging neuroscience into real-world applications and improve our collective brain & mental health. New thinking: Neuroscience tips about gratitude, aging, pain and the brain: An interview with Dr. Daniel Levitin What’s normal?…
Read MoreWill digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?
___ Akili Interactive: Digital pediatric ADHD therapeutic performs well with or without accompanying stimulant therapy (MobiHealth News): “Digital therapeutic company Akili Interactive has announced the first results of an open-label, multisite pediatric ADHD trial providing some patients with the company’s video game-like treatment alongside a stimulant medication. According to the company, both those who received…
Read MorePear Therapeutics raises $50M to develop and market a portfolio of digital therapeutics for mental health
___ Pear Therapeutics rakes in $50M to develop additional digital therapeutics (MobiHealthNews): “Boston- and San Francisco-based Pear Therapeutics, maker of a prescription digital therapeutic platform, announced today the closure of $50 million in Series B funding. The round was led by Singapore-based investment company Temasek, with participation from returning investors 5AM Ventures, Arboretum Ventures, and…
Read More